← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Alivio Therapeutics Inc
$6,564,931
Total funding
2
Grants
Funding over time
peak $3.3M · FY2018–20$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
Funding mix
By agency
DOD$6,564,931 · 2
By mechanism
—$6,564,931 · 2
Investigators at Alivio Therapeutics Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
AN ORAL, INFLAMMATION-TARGETING AND RESPONSIVE TACROLIMUS FORMULATION FOR THE TREATMENT OF STEROID-REFRACTORY AND STEROID-DEPENDENT INFLAMMATORY BOWEL DISEASE$3,299,610
· FY2020 · Department of the Army
DEVELOPMENT OF A LONG-ACTING LIDOCAINE FORMULATION FOR THE TREATMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME$3,265,321
· FY2018 · Defense Health Agency